MedPath

The usefulness of Cu-62 ATSM PET/CT to evaluate the sensitivity to radiotherapy for lung cancer and head and neck cancer

Not Applicable
Conditions
ung cancer and head and neck cancer
Registration Number
JPRN-UMIN000005616
Lead Sponsor
ational Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
47
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient under the psychological condition 2) Patient to whom imaging agents cannot be injected 3) Patient who was judged as unsuitable by the doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Accumulation of Cu-62 ATSM in the tumor
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath